NCT04286048 is a NA clinical trial of Weight implement in Baseball Pitcher, sponsored by Investigación en Hemofilia y Fisioterapia.

Who is sponsoring NCT04286048?

NCT04286048 is sponsored by Investigación en Hemofilia y Fisioterapia.

What drugs are being tested in NCT04286048?

Interventions in NCT04286048: Weight implement.

What condition does NCT04286048 study?

NCT04286048 studies Baseball Pitcher.

Is NCT04286048 still recruiting?

NCT04286048 is currently withdrawn. Last updated 5 September 2021.

Last reviewed 2021-09-05 · How we verify

NCT04286048

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Weight Implements to Improve Throwing Speed and Shoulder Mobility in Baseball Pitchers

Withdrawn NA Last updated 5 September 2021

What this trial tests

NA trial testing Weight implement in Baseball Pitcher. Withdrawn.

Timeline

2 March 2020

Primary endpoint
30 May 2020

10 June 2020

Quick facts

Lead sponsor	Investigación en Hemofilia y Fisioterapia
Phase	NA
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Start date	2 March 2020
Primary completion	30 May 2020
Estimated completion	10 June 2020
Sites	1 location across Spain

Drugs / interventions tested

Weight implement

Conditions studied

Baseball Pitcher — all drugs for Baseball Pitcher →

Sponsor

Investigación en Hemofilia y Fisioterapia

Who can join

Adults 18 to 40, male only, with Baseball Pitcher. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Increasing the speed of pitches is key in baseball performance. The interventions by means of the implement of weights are used to improve the strength and to strengthen the muscles of the shoulder. The objective of the study is to assess the effectiveness of an exercise protocol with weight implements in increasing the speed of throws and shoulder mobility in pitchers aged 18 to 40 years. Randomized pilot study. 12 pitchers will be randomized to the study groups: experimental (intervention with launches with weight implement) and control (without any intervention). The intervention will last 4 weeks, with 2 weekly sessions of 15 minutes each. The study variables will be the range of shoulder movement (goniometry) and the speed of the throws (speed radar). A descriptive statistical analysis will be performed calculating median and interquartile range. With the Shapiro-Wills test, the sample distribution will be calculated. If there is homogeneity, with the t-student test the changes will be calculated after the intervention in both groups. The intra and intersubject effect will be calculated with the ANOVA of repeated measures. The effect size will be obtained with Cohen's mean difference formula. It is expected to see improvement in the speed of the throws and in the range of shoulder movement.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Investigación en Hemofilia y Fisioterapia trials

Trials by the same sponsor.

NCT07516730 — Central Pain Mechanisms and Clinical and Psychological Factors Associated With Pain Interference in Daily Life in Adults · not yet recruiting
NCT07483541 — Identification of Modifiable Sleep-related Factors in Patients With Systemic Lupus Erythematosus. · not yet recruiting
NCT07420387 — Effectiveness of an Educational Program for Pain Management in Patients With Hemophilic Arthropathy · NA · not yet recruiting
NCT07420348 — Incidence of Ultrasonographically Detected Articular Damage in Initially Healthy Joints of Patients With Hemophilia A Re · not yet recruiting
NCT07123220 — Prognostic Factors for Fatigue in Patients With Systemic Lupus Erythematosus · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04286048 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Investigación en Hemofilia y Fisioterapia
Last refreshed: 5 September 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04286048.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing